Docoh
Loading...

TNYA Tenaya Therapeutics

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.

TNYA stock data

(
)

Calendar

8 Sep 21
26 Oct 21
31 Dec 21
Quarter (USD)
Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Cash on hand (at last report) 112.43M
Cash burn (monthly) 5.08M
Cash used (since last report) 19.67M
Cash remaining 92.76M
Runway (months of cash) 18.3

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
3 Aug 21 JeenJoo Kang Common Stock Conversion Acquire C No No 0 12,500 0 25,000
3 Aug 21 JeenJoo Kang Series A Preferred Stock Common Stock Conversion Dispose C No No 0 12,500 0 0
3 Aug 21 David V Goeddel Common Stock Conversion Acquire C Yes No 0 4,956,842 0 4,985,570
3 Aug 21 David V Goeddel Common Stock Conversion Acquire C Yes No 0 4,389,282 0 4,414,720
3 Aug 21 David V Goeddel Series C Preferred Stock Common Stock Conversion Dispose C Yes No 0 213,306 0 0
3 Aug 21 David V Goeddel Series C Preferred Stock Common Stock Conversion Dispose C Yes No 0 188,881 0 0
3 Aug 21 David V Goeddel Series B Preferred Stock Common Stock Conversion Dispose C Yes No 0 533,781 0 0
3 Aug 21 David V Goeddel Series B Preferred Stock Common Stock Conversion Dispose C Yes No 0 472,659 0 0
3 Aug 21 David V Goeddel Series A Preferred Stock Common Stock Conversion Dispose C Yes No 0 4,209,755 0 0
3 Aug 21 David V Goeddel Series A Preferred Stock Common Stock Conversion Dispose C Yes No 0 3,727,742 0 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Avg

Proxies

No filings